GF
SAGE

Gabelli Funds’s Sage Therapeutics SAGE Stock Holding History

Gabelli Funds’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200,777
Closed -$1.83M – 1291
2025
Q2 		$1.83M Buy
+200,777
New +$1.48M 0.01% 758

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli Funds's SAGE Position: Q3 2025 in Review

Gabelli Funds sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 200,777 shares — an estimated $1.83M sold.

Gabelli Funds first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $1.83M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Gabelli Funds reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Gabelli Funds sold 200,777 Sage Therapeutics shares in Q3 2025, an estimated $1.83M.
  • Gabelli Funds first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Gabelli Funds's Sage Therapeutics position peaked at $1.83M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.